How have ASNB shares performed in 2024?

EKIMAS's stock was trading at $0.62 on January 1st, 2024. Since then, ASNB shares have decreased by 1.6% and is now trading at $0.61. View the best growth stocks for 2024 here .

How were EKIMAS's earnings last quarter?

EKIMAS Co. (OTCMKTS:ASNB) issued its quarterly earnings results on Thursday, October, 16th. The company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.02. During the same period in the previous year, the firm earned $0.27 earnings per share.

What other stocks do shareholders of EKIMAS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other EKIMAS investors own include NVIDIA (NVDA) , Associated Banc (ASB) , PermRock Royalty Trust (PRT) , CytoDyn (CYDY) , FuelCell Energy (FCEL) , Interpace Biosciences (IDXG) , Sphere 3D (ANY) , AVEO Pharmaceuticals (AVEO) , Boeing (BA) and Bank of America (BAC) .

How do I buy shares of EKIMAS?

Shares of ASNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:ASNB

EKIMAS (ASNB) Stock Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Free ASNB Stock Alerts

$0.61

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.61
▼
$0.61
50-Day Range: $0.45
▼
$0.61
52-Week Range: $0.55
▼
$1.75

Volume: N/A
Average Volume: 3,162 shs
Market Capitalization: $3.54 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials SEC Filings

Get EKIMAS alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About EKIMAS

EKIMAS Corp. engages in the development of polymer materials, which provide characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The firm's products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Las Vegas, NV.

ASNB Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ASNB Stock News Headlines

March 8, 2023 | finance.yahoo.com

EKIMAS CORPORATION COMPLETES THE EXERCISE OF WARRANTS

March 1, 2023 | finance.yahoo.com

NORDICUS PARTNERS A/S COMPLETES REVERSE ACQUISITION TRANSACTION WITH EKIMAS CORPORTION

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

September 14, 2022 | reuters.com

ASNB.PK - Ekimas Corp | Stock Price & Latest News | Reuters

September 12, 2022 | finance.yahoo.com

Updated EKIMAS Corporation Announces Special Cash Distribution

September 10, 2022 | yahoo.com

What does ‘WYLL’ mean on TikTok and Snapchat?

August 28, 2022 | finance.yahoo.com

EKIMAS Corporation (ASNB)

See More Headlines

Receive ASNB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EKIMAS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 10/16/2014
Today: 4/18/2024
Fiscal Year End: 3/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: OTCMKTS:ASNB
Previous Symbol: AMEX:ASB
CUSIP: N/A
CIK: 1011060
Web: www.advbiomaterials.com
Phone: (424) 256-8560
Fax: 978-657-0074
Employees: 11
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-290,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -7,902.31%
Return on Assets: -5,274.01%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.12
Quick Ratio: 0.12

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.03 per share
Price / Book: 20.33

Miscellaneous

Outstanding Shares: 5,799,000
Free Float: 5,347,000
Market Cap: $3.54 million
Optionable: Not Optionable
Beta: 0.37

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Henrik Rouf
Chief Executive Officer
Bennett J. Yankowitz
Chief Financial Officer & Director

Key Competitors

View All Competitors

ASNB Stock Analysis - Frequently Asked Questions

How have ASNB shares performed in 2024?: EKIMAS's stock was trading at $0.62 on January 1st, 2024. Since then, ASNB shares have decreased by 1.6% and is now trading at $0.61.
View the best growth stocks for 2024 here.
How were EKIMAS's earnings last quarter?: EKIMAS Co. (OTCMKTS:ASNB) issued its quarterly earnings results on Thursday, October, 16th. The company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.02. During the same period in the previous year, the firm earned $0.27 earnings per share.
What other stocks do shareholders of EKIMAS own?: Based on aggregate information from My MarketBeat watchlists, some companies that other EKIMAS investors own include NVIDIA (NVDA), Associated Banc (ASB), PermRock Royalty Trust (PRT), CytoDyn (CYDY), FuelCell Energy (FCEL), Interpace Biosciences (IDXG), Sphere 3D (ANY), AVEO Pharmaceuticals (AVEO), Boeing (BA) and Bank of America (BAC).
How do I buy shares of EKIMAS?: Shares of ASNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ASNB) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial